NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 19.4
(-8.92%)
TWD 19.4
(-8.92%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 10.12 Million TWD | -66.29% |
| 2022 | 30.02 Million TWD | -2.54% |
| 2021 | 30.8 Million TWD | -52.83% |
| 2020 | 65.31 Million TWD | 64.54% |
| 2019 | 39.69 Million TWD | 367.95% |
| 2018 | -14.81 Million TWD | 75.51% |
| 2017 | -60.49 Million TWD | -0.81% |
| 2016 | -60.01 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 4.51 Million TWD | -32.89% |
| 2024 Q2 | 4.51 Million TWD | 0.0% |
| 2023 Q2 | 3.39 Million TWD | 100.0% |
| 2023 FY | 10.12 Million TWD | -66.29% |
| 2023 Q3 | 3.36 Million TWD | -0.78% |
| 2023 Q1 | 1.69 Million TWD | -86.47% |
| 2023 Q4 | 6.72 Million TWD | 100.0% |
| 2022 Q2 | 17.49 Million TWD | 0.0% |
| 2022 Q4 | 12.52 Million TWD | 0.0% |
| 2022 FY | 30.02 Million TWD | -2.54% |
| 2021 Q2 | -14.22 Million TWD | 0.0% |
| 2021 Q4 | 45.03 Million TWD | 0.0% |
| 2021 FY | 30.8 Million TWD | -52.83% |
| 2020 FY | 65.31 Million TWD | 64.54% |
| 2020 Q4 | 13.96 Million TWD | 0.0% |
| 2020 Q2 | 51.35 Million TWD | 0.0% |
| 2019 Q4 | 24.31 Million TWD | 0.0% |
| 2019 FY | 39.69 Million TWD | 367.95% |
| 2018 FY | -14.81 Million TWD | 75.51% |
| 2017 FY | -60.49 Million TWD | -0.81% |
| 2016 FY | -60.01 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 119.543% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 95.968% |
| Level Biotechnology Inc. | 62.9 Million TWD | 83.912% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 118.387% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 115.655% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 105.195% |
| GlycoNex Incorporation | -178.36 Million TWD | 105.674% |
| VBI | -6.6 Million TWD | 253.31% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 106.086% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 194.739% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 126.512% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 106.021% |
| Visgeneer Inc. | -19.58 Million TWD | 151.662% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 101.482% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 98.383% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 86.022% |
| Neith Corporation | -40.03 Million TWD | 125.279% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 100.873% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | 267.356% |
| Enimmune corporation | -223.74 Million TWD | 104.523% |
| TaiRx, Inc. | -212.29 Million TWD | 104.767% |
| CHO Pharma, Inc. | -306.08 Million TWD | 103.306% |
| EirGenix Inc. | -915.2 Million TWD | 101.106% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 79.655% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 115.982% |
| Lin BioScience, Inc. | -687.19 Million TWD | 101.473% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 106.474% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 55.598% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 113.809% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 121.371% |
| RBC Bioscience Corporation | 6.43 Million TWD | -57.387% |
| BiOptic Inc. | 37.74 Million TWD | 73.19% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 101.471% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 127.23% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 116.445% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 96.318% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 110.987% |
| NaviFUS Corp. | -65.72 Million TWD | 115.397% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 111.488% |
| Sinew Pharma Inc. | -170.92 Million TWD | 105.921% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 114.848% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 92.255% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 104.251% |
| AP Biosciences Inc | -339.29 Million TWD | 102.983% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 101.803% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 117.463% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | -19.678% |
| Intech Biopharm Corporation | -337.98 Million TWD | 102.994% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 100.771% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 119.607% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 105.929% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 98.124% |
| TCI GENE Inc. | 11.67 Million TWD | 13.304% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 107.934% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 103.415% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 104.653% |
| PharmaEngine, Inc. | 274.65 Million TWD | 96.315% |
| Savior Lifetec Corporation | 30.03 Million TWD | 66.3% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 92.599% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 100.967% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 108.074% |
| Acepodia, Inc. | -817.31 Million TWD | 101.238% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 102.072% |